These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6276787)

  • 1. Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence.
    Honerjäger P; Schäfer-Korting M; Reiter M
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):112-20. PubMed ID: 6276787
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
    Endoh M; Yamashita S; Taira N
    J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
    Ahn HS; Eardley D; Watkins R; Prioli N
    Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptor stimulation and cyclic AMP-dependent effects in guinea-pig ventricular myocardium.
    Schmied R; Korth M
    Br J Pharmacol; 1990 Feb; 99(2):401-7. PubMed ID: 1691677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
    Hayes JS; Bowling N; Boder GB; Kauffman R
    J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine.
    Takeda K; Matsui K; Nakazawa M; Nakahara H; Imai H; Imai S
    Jpn J Pharmacol; 1986 Mar; 40(3):381-8. PubMed ID: 3012165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ischemia-reperfusion on myocardial cyclic AMP and cyclic AMP phosphodiesterase: effects of amrinone on regional myocardial force and shortening.
    Tse J; Cimini C; Kedem J; Rodriquez E; Gonzalez M; Weiss HR
    J Cardiothorac Vasc Anesth; 1993 Oct; 7(5):566-72. PubMed ID: 8268438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
    Endoh M; Yanagisawa T; Taira N; Blinks JR
    Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA; Johnson DC
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses to amrinone in isolated cardiac muscles from cat, rabbit, and guinea pig.
    Siegl PK; Morgan G; Sweet CS
    J Cardiovasc Pharmacol; 1984; 6(2):281-7. PubMed ID: 6200717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle.
    Sys SU; Goenen MJ; Chalant CH; Brutsaert DL
    Circulation; 1986 Mar; 73(3 Pt 2):III25-35. PubMed ID: 3002662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive inhibition of phosphodiesterase activity by amrinone: its implication in the cardiac effect of the drug.
    Carpenedo F; Floreani M; Cargnelli G
    Pharmacol Res Commun; 1984 Oct; 16(10):969-77. PubMed ID: 6095329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical and mechanical effects of amrinone on isolated guinea pig ventricular muscle.
    Kondo N; Shibata S; Kodama I; Yamada K
    J Cardiovasc Pharmacol; 1983; 5(6):903-12. PubMed ID: 6196561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amrinone activates K+-depolarized atrial and ventricular myocardium of guinea pigs.
    Adams HR; Rhody J; Sutko JL
    Circ Res; 1982 Nov; 51(5):662-5. PubMed ID: 7139883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone.
    Earl CQ; Linden J; Weglicki WB
    J Cardiovasc Pharmacol; 1986; 8(4):864-72. PubMed ID: 2427830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of epinephrine and phosphodiesterase III inhibitors on bupivacaine-induced myocardial depression in guinea-pig papillary muscle.
    Azuma M; Yamane M; Tachibana K; Morimoto Y; Kemmotsu O
    Br J Anaesth; 2003 Jan; 90(1):66-71. PubMed ID: 12488382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies aimed at elucidating the mechanism of action of CI-914, a new cardiotonic agent.
    Weishaar RE; Quade M; Schenden JA; Boyd DK; Evans DB
    Eur J Pharmacol; 1985 Dec; 119(3):205-15. PubMed ID: 3004993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of phosphodiesterase inhibition and of carbachol on inotropic effects of 8-substituted cyclic AMP analogues.
    Korth M; Engels J; Schäfer-Korting M
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):166-75. PubMed ID: 2436059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of amrinone on contractility and taurine influx in rat and guinea pig hearts.
    Azari J; Huxtable RJ
    Eur J Pharmacol; 1980 Oct; 67(4):347-53. PubMed ID: 6256173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A report on the positive inotropic action of amrinone.
    Cargnelli G; Padrini R; Piovan D; Piacenza G; Ferrari M; Gallucci V
    Boll Soc Ital Biol Sper; 1982 Jul; 58(13):793-9. PubMed ID: 7126350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.